Literature DB >> 27747060

Adenocarcinoma containing lepidic growth.

Hisashi Iwata1.   

Abstract

Entities:  

Year:  2016        PMID: 27747060      PMCID: PMC5059295          DOI: 10.21037/jtd.2016.08.78

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  Whence lepidic?: the history of a Canadian neologism.

Authors:  Kirk D Jones
Journal:  Arch Pathol Lab Med       Date:  2013-08-12       Impact factor: 5.534

2.  Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity.

Authors:  Hisashi Iwata; Koyo Shirahashi; Yoshimasa Mizuno; Hirotaka Yamamoto; Hirofumi Takemura
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-20       Impact factor: 4.191

3.  Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.

Authors:  Morihito Okada; Haruhiko Nakayama; Sakae Okumura; Hiromitsu Daisaki; Shuji Adachi; Masahiro Yoshimura; Yoshihiro Miyata
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03-25       Impact factor: 5.209

4.  Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-20       Impact factor: 5.209

Review 5.  Anatomical thoracoscopic segmentectomy for lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-03

6.  A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).

Authors:  Kenji Suzuki; Teruaki Koike; Takashi Asakawa; Masahiko Kusumoto; Hisao Asamura; Kanji Nagai; Hirohito Tada; Tetsuya Mitsudomi; Masahiro Tsuboi; Taro Shibata; Haruhiko Fukuda; Harubumi Kato
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

7.  Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

8.  Is limited resection appropriate for radiologically "solid" tumors in small lung cancers?

Authors:  Aritoshi Hattori; Kenji Suzuki; Takeshi Matsunaga; Mariko Fukui; Yoshitaka Kitamura; Yoshikazu Miyasaka; Yukio Tsushima; Kazuya Takamochi; Shiaki Oh
Journal:  Ann Thorac Surg       Date:  2012-05-04       Impact factor: 4.330

9.  Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.

Authors:  Ken Kodama; Masahiko Higashiyama; Jiro Okami; Toshiteru Tokunaga; Fumio Imamura; Tomio Nakayama; Atsuo Inoue; Keiko Kuriyama
Journal:  Ann Thorac Surg       Date:  2015-11-03       Impact factor: 4.330

10.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

View more
  2 in total

1.  CEA-Ki-67- Pathologic Subtype: An Adjunct Factor for Refining Prognosis in Stage I Pulmonary Adenocarcinoma.

Authors:  Dongzhi Yu; Yanbin Sun; Michael A McNutt; Shun Xu
Journal:  Front Surg       Date:  2022-04-25

2.  Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.

Authors:  Timothy J Young; Ramin Salehi-Rad; Reza Ronaghi; Jane Yanagawa; Puja Shahrouki; Bianca E Villegas; Brian Cone; Gregory A Fishbein; William D Wallace; Fereidoun Abtin; Igor Barjaktarevic
Journal:  Med Sci (Basel)       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.